|
2016-04-18 14:59:30 |
LM Synevo Wrocław (W) - Fieldorfa 2 |
|
[{"Badanie":"Rodzaj materia\u0142u:","Wynik":"Ropa","Jednostka":null,"Norma":null},{"Badanie":"Data pobrania materia\u0142u","Wynik":"18-04-2016","Jednostka":null,"Norma":null},{"Badanie":"Osoba pobieraj\u0105ca materia\u0142","Wynik":null,"Jednostka":null,"Norma":null},{"Badanie":"Wynik badania:","Wynik":"Ujemny","Jednostka":null,"Norma":null},{"Badanie":"Data uko\u0144czenia bada\u0144:","Wynik":"24-04-2016","Jednostka":null,"Norma":null},{"Badanie":"Uwagi:","Wynik":null,"Jednostka":null,"Norma":null}] |
|
2026-08-13 22:33:34 |
Laboratory report.total_509752_2016_04_18.xml |
|
2016-04-18 15:05:26 |
LM Synevo Wrocław (W) - Fieldorfa 2 |
|
[{"Badanie":"Rodzaj materia\u0142u:","Wynik":"Ropa","Jednostka":null,"Norma":null},{"Badanie":"Data pobrania materia\u0142u","Wynik":"18-04-2016","Jednostka":null,"Norma":null},{"Badanie":"Osoba pobieraj\u0105ca materia\u0142","Wynik":null,"Jednostka":null,"Norma":null},{"Badanie":"Wynik badania:","Wynik":"Ujemny","Jednostka":null,"Norma":null},{"Badanie":"Data uko\u0144czenia bada\u0144:","Wynik":"24-04-2016","Jednostka":null,"Norma":null},{"Badanie":"Uwagi:","Wynik":null,"Jednostka":null,"Norma":null}] |
|
2026-08-13 22:33:34 |
Laboratory report.total_509752_2016_04_18_1.xml |
|
2016-04-21 08:41:45 |
LM Synevo Wrocław (W) - Fieldorfa 2 |
|
[{"Badanie":"Glukoza","Wynik":"105","Jednostka":"mg/dl","Norma":"70 \u0097 99"}] |
|
2026-08-13 22:33:34 |
Laboratory report.total_509752_2016_04_21.xml |
|
2016-06-30 08:07:20 |
LM Synevo Wrocław (W) - Fieldorfa 2 |
|
[{"Badanie":"Cholesterol ca\u0142kowity","Wynik":"180","Jednostka":"mg/dl","Norma":"\u003C 190"},{"Badanie":"Cholesterol HDL","Wynik":"33,7","Jednostka":"mg/dl","Norma":"\u003E 45,0"},{"Badanie":"Cholesterol LDL","Wynik":"118,12","Jednostka":"mg/dl","Norma":"Warto\u015Bci docelowe st\u0119\u017Ce\u0144:\n\nChoroba wie\u0144cowa, mia\u017Cd\u017Cyca innych t\u0119tnic, stan po udarze m\u00F3zgu, cukrzyca, choroby nerek \u003E= 4 stadium lub inne czynniki ryzyka: \u003C 70 mg/dl (\u003C 1,8 mmol/l)\n\nInne czynniki ryzyka lub choroba nerek \u003E 3 stadium: \u003C 100 mg/dl (\u003C 2,5 mmol/l)\n\nMniejsze ryzyko sercowo - naczyniowe: \u003C 115 mg/dl (\u003C 3 mmol/l)"},{"Badanie":"Triglicerydy (jedn. tradyc.)","Wynik":"143","Jednostka":"mg/dl","Norma":"\u003C 150"},{"Badanie":"AST","Wynik":"22","Jednostka":"U/l","Norma":"\u003C 32"},{"Badanie":"Glukoza","Wynik":"99","Jednostka":"mg/dl","Norma":"70 \u0097 99"}] |
|
2026-08-13 22:33:34 |
Laboratory report.total_509752_2016_06_30.xml |
|
2016-06-30 08:07:58 |
LM Synevo Wrocław (W) - Fieldorfa 2 |
|
[{"Badanie":"ALT","Wynik":"31","Jednostka":"U/l","Norma":"\u003C 31"}] |
|
2026-08-13 22:33:34 |
Laboratory report.total_509752_2016_06_30_1.xml |